Tuesday, August 14, 2018

Revision of ceiling rates for reimbursement of the cost of Cardiac pacemaker, AlCD, Combo-device, Rotablator and Aortic Stent Graft for beneficiaries of CGHS/CS(MA) Rules

Posted by Government Staff on 7:59 AM. ,,,,,,,, - No comments

Revision of ceiling rates for reimbursement of the cost of Cardiac pacemaker, AlCD, Combo-device, Rotablator and Aortic Stent Graft for beneficiaries of CGHS/CS(MA) Rules.

Government of India
Ministry of Health and Family Welfare
Department of Health & Family Welfare
Directorate General of CGHS
Office of the Director, CGHS

No: S-11011/29/2018-CGHS(HEC)/ DIR/CGHS
Nirman Bhawan, New Delhi
Dated the 6th August, 2018
OFFICE MEMORANDUM

Subject:- Revision of ceiling rates for reimbursement of the cost of Cardiac pacemaker, AlCD, Combo-device, Rotablator and Aortic Stent Graft for beneficiaries of CGHS/CS(MA) Rules.

With reference to the above subject attention is drawn to the OM No 12034/02/2014/Misc./- CGHS D.lll dated 22nd July 2014 vide which ceiling rates for reimbursement of the cost of Cardiac pacemaker, AICD, Combo-device, Rotablator and Aortic Stent Graft for beneficiaries of CGHS/CS (MA) Rules were prescribed and to state that the matter has been reviewed by the Ministry and it is decided to revise the ceiling rates as per the details given under:

Sl.No. Cardiac Device Ceiling Rate
1Single Chamber Cardiac Pacemaker without Rate ResponseRs.34,840/- + GST
2Single Chamber Cardiac Pacemaker with Rate ResponseRs. 44,9281-+ GST
3Dual Chamber Cardiac PacemakerRs.83,200/-+ GST
4Bi-Ventricular Cardiac PacemakerRs.1,95,000/-+ GST
5Implantable Cardioverter Defibrillator (Single Chamber) (ICD/AICD-Single Chamber)Rs.1,75 786/-4+ GST
6Implantable Cardioverter Defibrillator (Dual Chamber) (ICD/AICD-Single Chamber)Rs. 3,75,000/-+ GST
7Combo Device (CRT-D)Rs, 4.90,000/-+ GST
8Aortic Stent Graft (expandable, bifurcated and including delivery system)Rs. 4,40.960/- + GST
9Rotablator with AdvancerRs.49,920/-+ GST
10Rotablator BurrRs.23,920/-+ GST

2. Other terms and conditions prescribed under OM No 12034/02/2014/Misc./-CGHS D.III dated 22nd July 2014 shall remain unchanged.

3. These rates shall remain valid till the rates for the above devices are notified by National Pharmaceutical Pricing Authority (NPPA).

4. Issued with the concurrence of SS&FA, Ministry of Health & Family Welfare vide CD - No.1295 dated 25.07.2018.
(Dr. Atul Prakash)
Director, CGHS

0 comments:

Post a Comment

Now Trending

34% DA Order for Central Govt Employees wef 01.01.2022 - Latest CG Employees DA Order Jan 2022

 DA Order for Central Government Employees from Jan 2022 - Finmin Order 2022 Latest CG Employees DA Order Jan 2022 Dearness Allowance payabl...

Disclaimer:

All efforts have been made to ensure accuracy of the content on this blog, the same should not be construed as a statement of law or used for any legal purposes. Our blog "Central Government Staff news" accepts no responsibility in relation to the accuracy, completeness, usefulness or otherwise, of the contents. Users are advised to verify/check any information with the relevant department(s) and/or other source(s), and to obtain any appropriate professional advice before acting on the information provided in the blog.

Links to other websites that have been included on this blog are provided for public convenience only.

The blog "Central Government Staff news" is not responsible for the contents or reliability of linked websites and does not necessarily endorse the view expressed within them. We cannot guarantee the availability of such linked pages at all times.

Any suggestions write to us
centralgovernmentnews@gmail.com